Cleared Traditional

K231103 - ROSA ONE Brain Application

K231103 is an FDA 510(k) clearance for ROSA ONE Brain Application, manufactured by Medtech S.A.S. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K231103 · Medtech S.A.S · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
92d
Days
Class 2
Risk

K231103 is an FDA 510(k) clearance for the ROSA ONE Brain Application. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Medtech S.A.S (Mauguio, FR). The FDA issued a Cleared decision on July 20, 2023 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtech S.A.S devices

FDA 510(k) Submission Details - K231103

510(k) Number K231103 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2023
Decision Date July 20, 2023
Days to Decision 92 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 148d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 257
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K231103.
Alignment System Cranial, Alignment Software Cranial, Cirq Alignment Software Cranial Biopsy, Cirq Alignment Software Cranial sEEG, Varioguide Alignment Software Cranial
K223864 · Brainlab AG · Sep 2023
Zeta Cranial Navigation System
K230661 · Zeta Surgical · Sep 2023
Cranial Navigation, Navigation Software Cranial, Navigation Software Craniofacial, Cranial EM System, Automatic Registration iMRI
K223288 · Brainlab AG · Jul 2023
NaviNetics Reusable Stereotactic System (NN1000)
K231392 · Navinetics, Inc. · Jul 2023
Sinobot X1
K220072 · Sinovation (Beijing) Medical Technology Co., Ltd. · Jun 2023
Brainlab Elements – Trajectory Planning (2.6), Elements Stereotaxy, Elements Lead Localization, Elements Trajectory Planning Cranial
K223552 · Brainlab AG · Apr 2023